Cynata Therapeutics Limited
Cynata Therapeutics Limited
Your view on CYP.AX
Overview
What the company does, where it operates, and who runs it.
About Cynata Therapeutics Limited
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Kilian Kelly
- Headquarters
- 100 Cubitt Street, Cremorne, VIC, AU
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Kilian Kelly
- Headquarters
- 100 Cubitt Street, Cremorne, VIC, AU
Headquartered in Cremorne, Australia, Cynata Therapeutics Limited, established in 2003 and formerly known as Eco Quest Limited until its 2013 rebranding, specializes in the development and commercialization of its proprietary Cymerus mesenchymal stem cell technology for human therapeutic applications.
Its most advanced therapeutic candidate, CYP-001, has successfully concluded Phase I clinical trials for graft versus host disease. The company's pipeline also includes CYP-004, currently in Phase III trials for osteoarthritis treatment, and CYP-006TK, an innovative polymer-coated silicon wound dressing designed for diabetic wounds.
Furthermore, Cynata is advancing therapies for a broad spectrum of conditions such as asthma, heart attacks, coronary artery disease, acute respiratory distress syndrome, brain cancer, sepsis, critical limb ischemia, idiopathic pulmonary fibrosis, and renal transplantation.
Cynata maintains a crucial strategic alliance with Fujifilm, which is responsible for the clinical and commercial manufacturing and supply of its Cymerus therapeutic mesenchymal stem cell products.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Cynata Therapeutics Limited. Starting points for Cynata Therapeutics Limited: EPS -AUD 0.04, beta 1.12 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Cynata Therapeutics Limited. Cynata Therapeutics Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Cynata Therapeutics Limited. Trailing twelve-month EPS for Cynata Therapeutics Limited stands at -AUD 0.04. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Cynata Therapeutics Limited. Cynata Therapeutics Limited has reported as a listed company since 2007. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| OCGNOcugen, Inc. | Healthcare | NASDAQ | $250.8M | ||
| OCSOculis Holding AG | Healthcare | NASDAQ | $456.2M | ||
| OCULOcular Therapeutix, Inc. | Healthcare | NASDAQ | $1.3B | ||
| ODTXOdyssey Therapeutics, Inc. | Healthcare | NASDAQ | $912.3M | ||
| OGENOragenics, Inc. | Healthcare | AMEX | $852,760 | ||
| OKUROnKure Therapeutics, Inc. | Healthcare | NASDAQ | $114.2M | ||
| OKYOOKYO Pharma Limited | Healthcare | NASDAQ | $57.7M | ||
| OLMAOlema Pharmaceuticals, Inc. | Healthcare | NASDAQ | $618.5M | ||
| OMEROmeros Corporation | Healthcare | NASDAQ | $1.1B | ||
| ONCBeOne Medicines Ltd. | Healthcare | NASDAQ | $43.1B | ||
| ONCOOnconetix, Inc. | Healthcare | NASDAQ | $1.1M | ||
| ONCO.NEOnco-Innovations Limited | Healthcare | NEO | — | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Cynata Therapeutics Limited. Coverage tracks Cynata Therapeutics Limited within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Cynata Therapeutics Limited.